$0.70
-0.04 (-5.61%)
ICCM News2 articles
IceCure Medical Surges on ProSense Uptick and $5.5M Financing
IceCure Medical shares soared 200% after revealing a 70% jump in U.S. ProSense breast cancer cryoablation installs and a $5.5 million private placement, as the market balances rapid adoption against potential dilution.
IceCure Medical Soars on 70% U.S. ProSense Install Base Growth Post-FDA Clearance
IceCure Medical shares tripled on news of a 70% U.S. install base growth for its ProSense breast cancer cryoablation system following FDA clearance.